Elanco Animal Health Inc - COMMON STOCK (ELAN)

Historical Holders from Q1 2016 to Q3 2025

Symbol: ELAN on NYSE
Type / Class: Equity / COMMON STOCK
Shares outstanding: 492,937,031
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 570,763,093
Holdings value: $11,494,667,666
% of all portfolios: 0.007%
Number of holders: 401
Number of buys: 234
Number of sells: -146
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Elanco Animal Health Inc - COMMON STOCK (ELAN)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
FMR LLC	13.1%	+31%	$975,846,299	+$230,747,801	64,883,397	+31%	FMR LLC	30 Jun 2025
BlackRock, Inc.	8.9%	+1.1%	$886,598,367	+$443,042,097	44,021,766	+99.9%	BlackRock, Inc.	30 Sep 2025
T. Rowe Price Investment Management, Inc.	6.4%		$635,376,116		31,547,970		T. Rowe Price Investment Management, Inc.	30 Sep 2025

Institutional Holders of Elanco Animal Health Inc - COMMON STOCK (ELAN)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	570,763,093	$11,494,667,666	+$680,251,265	$21,762,648	$15,679,043	$20.14	401
2025 Q2	538,352,937	$7,687,668,693	+$655,647,979	$20,244,633	$12,392,528	$14.28	362
2025 Q1	494,022,445	$5,187,492,485	+$2,004,620	$7,043,028	$7,532,565	$10.5	359
2024 Q4	489,345,019	$5,925,862,528	+$26,438,350	$13,607,690	$13,981,675	$12.11	387
2024 Q3	481,862,274	$7,076,192,785	-$28,345,131	$11,046,851	$67,858,714	$14.69	384
2024 Q2	482,171,600	$6,957,441,182	+$6,686,922	$18,011,526	$43,923,477	$14.43	396
2024 Q1	480,177,163	$7,816,997,297	+$26,389,803	$14,912,080	$42,350,392	$16.28	370
2023 Q4	479,962,841	$7,151,250,374	+$21,579,978	$14,803,150	$25,300,200	$14.9	349
2023 Q3	481,442,000	$5,409,895,330	+$102,163,765	$9,987,864	$13,102,468	$11.24	344
2023 Q2	473,375,354	$4,760,610,377	-$67,531,728	$13,094,660	$22,092,276	$10.06	345
2023 Q1	479,522,703	$4,495,944,050	-$110,942,259	$12,551,340	$21,413,840	$9.4	384
2022 Q4	481,681,648	$5,908,155,843	+$232,156,887	$16,010,818	$36,670,570	$12.22	398
2022 Q3	463,043,345	$5,755,609,685	-$196,296,127	$14,931,000	$87,595,000	$12.41	398
2022 Q2	470,431,046	$9,236,728,928	-$88,523,747	$14,360,000	$12,292,000	$19.63	421
2022 Q1	473,375,688	$12,362,622,405	-$47,241,309	$34,154,000	$22,290,000	$26.09	454
2021 Q4	475,123,500	$13,465,426,403	+$218,382,206	$64,782,000	$31,495,000	$28.38	461
2021 Q3	467,401,656	$14,907,014,269	-$71,757,204	$28,394,000	$52,288,000	$31.89	435
2021 Q2	468,283,929	$16,250,367,215	+$128,764,524	$59,504,000	$57,139,000	$34.69	464
2021 Q1	467,015,636	$13,752,652,796	+$242,000,095	$100,579,090	$46,009,875	$29.45	433
2020 Q4	458,146,787	$14,050,001,284	+$1,375,218,703	$85,036,654	$38,677,250	$30.67	424
2020 Q3	413,516,389	$11,539,620,540	+$535,290,448	$60,861,000	$18,583,000	$27.93	348
2020 Q2	396,250,140	$8,506,918,630	-$172,335,832	$17,364,000	$37,905,000	$21.45	355
2020 Q1	402,762,228	$9,017,316,731	+$571,966,377	$23,942,000	$31,386,000	$22.39	350
2019 Q4	369,452,160	$10,879,469,608	-$57,025,660	$30,447,000	$30,917,000	$29.45	390
2019 Q3	371,517,866	$9,877,782,405	-$152,630,501	$44,177,000	$23,183,000	$26.59	359
2019 Q2	374,935,481	$12,675,665,904	+$446,834,964	$20,321,000	$17,468,000	$33.8	364
2019 Q1	373,768,060	$11,987,183,816	+$9,247,514,461	$52,424,000	$33,956,000	$32.07	342
2018 Q4	85,024,329	$2,681,019,350	+$393,741,056	$1,220,000	$136,000	$31.53	164
2018 Q3	71,099,284	$2,480,509,428	+$2,480,239,432			$34.89	153
2016 Q2	0	$0	-$6,000				0
2016 Q1	186	$6,000				$32.26	1